Jana K. Shirey-Rice, Ph.D.
Institution:
Vanderbilt University, Nashville, TNGoogle:
"Jana Shirey-Rice"Mean distance: 15.13 (cluster 6)
Parents
Sign in to add mentor| Jeffrey P. Conn | grad student | 2010 | Vanderbilt | |
| (M1 and M4 muscarinic acetylcholine receptor regulation of neurotransmission and cell excitability in rodent hippocampus and prefrontal cortex.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jerome RN, Joly MM, Kennedy N, et al. (2020) Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Drug Safety |
| Pulley JM, Rhoads JP, Jerome RN, et al. (2019) Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data. Annual Review of Pharmacology and Toxicology |
| Jerome RN, Pulley JM, Roden DM, et al. (2018) Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors". Drug Safety |
| Pulley JM, Jerome RN, Zaleski NM, et al. (2017) When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. Assay and Drug Development Technologies. 15: 354-361 |
| Jerome RN, Pulley JM, Roden DM, et al. (2017) Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. Drug Safety |
| Pulley JM, Shirey-Rice JK, Lavieri RR, et al. (2017) Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. Assay and Drug Development Technologies |
| Giltnane JM, Shirey-Rice J, Linder J, et al. (2015) Abstract 222: PathLink: Leveraging clinical informatics to empower translational pathology by connecting biospecimens to outcomes Cancer Research. 75: 222-222 |